Ilexgenin A, rosmarinic acid, and lupeol target proinflammatory cytokines, such as TNF-α, to inhibit VEGF and ultimately provide relief against the pain in cancer immunotherapy [87,88,112,134]. The gene discussed is TNF; the disease is cancer.